ABSTRACT
INTRODUCTION
Medicinal and aromatic plants (MAPs) have been used in traditional medicine in all parts of the world since the ancient times, and nowadays interest in using both different MAPs and products derived from MAPs have continued almost in all sectors and industries. 1, 2 In recent years, a large number of secondary metabolites, including essential oils (EOs) are considered as valuable sources for ingredients in food and pharmaceutical industries, cosmetics and medicinal applications for prevention and/or treatment of many diseases including neurodegenerative diseases, rheumatoid arthritis, diabetes, respiratory diseases, cardiovascular diseases, cancers and inflammatory and oxidative diseases. 2, 3 EOs extracted from MAPs, contain 300 compounds such as limonene, -pinene, -myrcene, -elemene, caryophyllene, humulene, -farnesene, cembrene, kaurene, eucalyptol, camphorene, camphor, carveol, limonene oxide, caryophyllene oxide, farnesol, humulene epoxide, -bisabolene oxide, carvacrol, catechol, eugenol, isopropyl alcohol, butyl alcohol, perillyl alcohol, geraniol, nerol, safrole, sesquiterpenes, rosmarinic acid, nerolidol, benzophenone, bornyl acetate, ethyl acetate, vernolide, cinnamaldehyde, acetophenone, helenin, fumarin, benzofuran etc., that exhibit many biological properties including antibacterial, antifungal, antioxidant, antiulcer, antispasmodic, antiproliferative, antitumor, antihepatotoxic, and others. EOs have thus become a focal point to improve and maintain human health needs and treatment of the diseases with less side effects. [3] [4] [5] Previous researches both in vivo and in vitro showed that EOs possess major bioactive components and molecules, which have chemoprevention and cancer suppression activities. EOs have also been demonstrated to have potentials to fight against cancer cells by multiple pathways and mechanisms, including of apoptosis and cell cycle arrest, angiogenesis and cell proliferation, of DNA damage and to repair signaling and activation of detoxification enzymes such as glutathione reductase, catalase glutathione, superoxide dismutase, peroxidase, etc.
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R. officinalis L., also known as rosemary, is native to the Mediterranean region and grown in many parts of the world. Possesses a wide range of biological activities and medicinal uses, particularly for the treatment of central nervous system complaints, liver, respiratory and genito-urinary disorders, cancer gastrointestinal and cardiovascular diseases. [6] [7] [8] In addition to its medicinal uses, it has been used for culinary, food flavoring and spice, cosmetics, and perfumery applications. 9, 10 Recent studies revealed that rosemary EOs have greater biological effects than its extracts since the EOs have higher contents of major bioactive components, especially polyphenols and phenylpropanoids such as rosmarinic acid, carnosic acids, camphor, camphene, α-pinene, β-pinene, borneol, caryophyllene, limonene, terpineol and myrcene. [8] [9] [10] [11] [12] P. alba L., known as white poplar, growing in a wide range of environmental conditions, is belonging to the family Salicaceae and native to central and southern Europe. 13 Although there were some previous investigations on the EO of P. alba , to the best of our knowledge, this is the first report of its in vitro anticancer and antiproliferative activities. Contrary to rosemary extracts, which have been widely investigated for their anticancer effects, the EOs of rosemary and white poplar have not yet been thoroughly investigated for their biological activities especially antioxidant, antiproliferative and cytotoxic properties. Therefore, we have evaluated potential antioxidant properties, lipid peroxidation capacity, in vitro cytotoxic and antiproliferative activities of EOs extracted from P. alba L. and R. officinalis L. against three human cancer cell lines: A549 cells (human lung adenocarcinoma), H1299 (human non-small lung cancer) and MCF-7 (human breast adenocarcinoma), obtained from the American Type Culture Collection (ATCC).
MATERIALS AND METHODS

Plant material:
The aerial parts of P. alba L. and R. officinalis L. were collected from Gaziantep, south eastern Anatolia of Turkey, and kept at laboratory conditions at room temperature (25°C) with no direct light until the extraction.
Extraction of EOs:
The leaves and flowers of P. alba L. and R. officinalis L. were used for extraction of EOs. All the plant parts (100 g for each plant species) were extracted separately by hydrodistillation using a Clevenger Apparatus for 4h at 100±5°C, and the extracted oils were dried over anhydrous Na 2 SO 4 , then the pure essential oils were obtained and stored at 4°C for further analysis.
In vitro anticancer activity assay by MTT method:
MTT assay was carried out to determine the potential antiproliferative and cytotoxic properties of the EOs from P. alba L. and R. officinalis L. against three human cancer cell lines: A549 cells (human lung adenocarcinoma), H1299 (human non-small cell lung cancer), MCF-7 (human breast adenocarcinoma), and non-tumor HUVEC cells, obtained from the American Type Culture Collection (ATCC). MTT assay was performed as previously reported by Al-Qubaisi et al.
14 with minor modifications. Cells were cultured on RPMI-1640 medium, supplemented with 10% fetal bovine serum, 100 U/mL penicillin and 100 µg/mL streptomycin in the flasks with 5% CO 2 at 37°C. The 5 x 10 3 cells per mL were treated with EOs with concentrations of 0, 1, 10, 100 µM, and incubated at 37°C for 48h. After incubation, 50 µL/well of MTT solution was added into each well, then the OD was measured at 570 nm and the inhibition (%) was calculated as;
[(mean OD without test agent (negative control) -mean OD with test agent / mean OD without test agent (negative control)] × 100
In vitro antioxidant activity assay by DPPH method: Antioxidant activity was determined using microplate 2,2-diphenyl-2-picrylhydrazyl (DPPH) assay described by Molyneux 15 with some modifications. Ascorbic acid was used as standard. The absorbance value was measured at 517 nm using a spectrophotometer in triplicate. The inhibition of the DPPH scavenging activity was calculated using the following formula: % DPPH scavenging activity = (1-A 517 sample / A 517 control ) × 100
Where A control is the absorbance of all the reagents except the test sample, A sample is the absorbance of the EOs. Ascorbic acid was used as standard antioxidant. In order to determine IC 50 values (scavenge 50% of the DPPH radicals) of the EOs, a linear regression analysis was used. Lipid peroxidation activity assay by TBARS method: Lipid peroxidation activity was evaluated using thiobarbituric acid-reactive substances (TBARS) method described by Raharjo et al. 16 and Ferreira et al.
17
, 2-thiobarbituric acid (TBA) was used as indicator and 1,1,3,3-tetraethoxypropane (TEP) as standard. The absorbance of organic upper layer was read at 532 nm using a spectrophotometer in triplicate, and the TBARS values were expressed in terms of malondialdehyde (MDA) equivalents for quantifying lipid peroxides. The lipid peroxidation inhibition was calculated as;
Inhibition ratio (%) = (1-A 532 sample / A 532 control ) × 100
Where A control is the absorbance of the control and A sample is the absorbance of the sample solution. IC 50 values (50% of the lipid peroxidation inhibition) of the EOs were calculated and compared with the standard. Statistical analysis: All the assays were conducted in triplicate, three different microplate wells were used to evaluate for each concentration of the EOs. A linear regression analysis was performed to calculate IC 50 values. P value of <0.01 was considered statistically very significant.
RESULTS AND DISCUSSION
The EOs from P. alba L. and R. officinalis L. were evaluated for their in vitro cytotoxic, antiproliferative, antioxidant and lipid peroxidation activities. Cytotoxicity (IC 50 values after 48h treatment period) of the EOs from P. alba L. and R. officinalis L. to three cancer cell lines (A549, H1299, and MCF-7) and to the non-tumor HUVEC cells are given in the Table 1 . The EOs of P. alba L. and R. officinalis L. exhibited strong cytotoxic and antiproliferative properties against all the three tested human cancer cell lines, in a dose and time dependent manner. However, EO of R. officinalis was found to be more active (IC 50 values ranging from 3.06 to 7.38 µg/mL) than that of P. alba (IC 50 values ranging from 12.05 to 28.16 µg/mL). Interestingly, the EOs from both plants showed a selectivity toward the cancer cell lines, exhibiting strong activity against A459 and H1299 cells, moderate activity against MCF-7 and weak activity against the non-tumor HUVEC cells (IC 50 > 30 µg/mL). The strong growth inhibition of EO from R. officinalis could be due to the presence of the cytotoxic components such as carnasol, methyl carnosate, carnosic and rosmarinic acids. 5, [6] [7] [8] [9] Although this is the first report of the cytotoxic and antiproliferative effects of the EO from P. alba , it is probable that saponins, which are present in this EO, could contribute to these effect. 13 The results of in vitro antioxidant activity, expressed as IC 50 values obtained from DPPH radical scavenging activity and lipid peroxidation activity by TBARS method, of the EOs from P. alba L. and R. officinalis L. are shown in Table 2 . The EOs from both sources showed significant free radical scavenging activities against DPPH by when compared their values of IC 50 with commercial with that of ascorbic acid, a commercial standard AA (IC 50 = 12.64 ± 0.32 µg/mL). The EO from R. officinalis L. was found to have higher free radical scavenging activity, with IC 50 at 10.08 ± 0.15 µg/mL (p<0.01), 18.05 ± 0.38 µg/mL (p<0.05) Polyphenols and phenylpropanoids, found in the rosemary oil are most likely responsible for a strong radical scavenging activity. 7, 9, 20 The results of lipid peroxides radical scavenging capacity for both of the EOs, presented in Table 2 , are consistent with the DPPH radical scavenging activity results. They were able to reduce the lipid peroxides radicals with IC 50 of 1.76 ± 0.02 and 2.16 ± 0.14 respectively (p<0.05). The values of IC 50 were compared with the commercial standard BHT. This indicates that the rosemary and white poplar EOs were able to inhibit the free lipid 
CONCLUSION
However, further studies using cell culture and animal models to understand the mechanisms underlying the cytotoxicity and anticancer activity of these EOs are needed to better understand the biological events and molecular targets of EOs to safeguard their usage as therapeutic agents. In the near future, it would be possible to develop therapeutic drugs containing rosemary and white poplar EOs. 
